drugset / Trial / NCT02053922
The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The use of Oxytocin, Carbetocin and buccal misoprostol in patients undergoing elective Cesarean Section
Timeline
- Start
- 2012-12
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbetocin | Peptide | 100 ug/ml | Intravenous |
| Comparator | Misoprostol | Other / unclassified | 400 ug | Other |
| Comparator | Oxytocin | Peptide | 20 iu | Intravenous |
Indications
No indication recorded.